[Production of monoclonal antibodies against osteoclasts of rat]. 1993

H Maeda, and T Kukita, and A Akamine, and T Iijima
Department of Conservative Dentistry, Faculty of Dentistry, Kyushu University, Fukuoka.

In mammals, it has been difficult to collect the authentic osteoclasts on a large scale. Recently we established a culture system for forming osteoclast-like multinucleated cells (MNCs) which exhibited many characteristics of osteoclasts. MNCs instead of authentic osteoclasts were used as immunogen to establish the hybridomas which secrete monoclonal antibodies against the osteoclasts by in vitro immunization. We obtained two monoclonal antibodies, HOK 1 and HOK 2. HOK 1 showed intense immunoreactivity with MNCs, mononuclear cells and putative migratory traces of MNCs on the culture dishes, but it had weak reactivity with the stromal cells. HOK 2 also showed strong reactivity with MNCs, mononuclear cells, and the very limited area of the culture dishes just facing to one side of some MNCs. The stromal cells were faintly stained with HOK 2. In th paraffin sections of tibiae, both antibodies intensely stained osteoclasts, osteoblasts and osteocytes. The bone matrix was weakly stained by HOK 2 but not by HOK 1. The present observations indicated that HOK 1 and HOK 2 could recognize the common antigen expressed on cells both involving in the bone formation and resorption. The antigens recognized by HOK 1 and HOK 2 were shown to exist on the putative traces of motile MNCs. These antibodies would be available to investigate the mechanisms of the 'bone remodeling' as a functional marker of bone cells.

UI MeSH Term Description Entries
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016723 Bone Remodeling The continuous turnover of BONE MATRIX and mineral that involves first an increase in BONE RESORPTION (osteoclastic activity) and later, reactive BONE FORMATION (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium HOMEOSTASIS. An imbalance in the regulation of bone remodeling's two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS. Bone Turnover,Bone Turnovers,Remodeling, Bone,Turnover, Bone,Turnovers, Bone
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Maeda, and T Kukita, and A Akamine, and T Iijima
April 1986, Bone and mineral,
H Maeda, and T Kukita, and A Akamine, and T Iijima
July 1983, Laboratory investigation; a journal of technical methods and pathology,
H Maeda, and T Kukita, and A Akamine, and T Iijima
November 1991, Calcified tissue international,
H Maeda, and T Kukita, and A Akamine, and T Iijima
February 2010, Hybridoma (2005),
H Maeda, and T Kukita, and A Akamine, and T Iijima
June 1998, Hybridoma,
H Maeda, and T Kukita, and A Akamine, and T Iijima
February 2006, Hybridoma (2005),
H Maeda, and T Kukita, and A Akamine, and T Iijima
January 1985, Comparative biochemistry and physiology. B, Comparative biochemistry,
H Maeda, and T Kukita, and A Akamine, and T Iijima
September 1990, Thrombosis research,
H Maeda, and T Kukita, and A Akamine, and T Iijima
September 1994, Journal of immunological methods,
H Maeda, and T Kukita, and A Akamine, and T Iijima
June 2020, Journal of acupuncture and meridian studies,
Copied contents to your clipboard!